@Article{Ifamela2026,
journal="Dermatology Review/Przegląd Dermatologiczny",
issn="0033-2526",
volume="113",
number="1",
year="2026",
title="Psoriasis in Pregnancy",
abstract="   Psoriasis is a chronic immune-mediated inflammatory skin  disease, with one of its incidence peaks occurring during the  reproductive years, including pregnant women. Immunological and  hormonal changes during pregnancy may influence the course of  psoriasis, leading to improvement, worsening, or no change in disease  activity. Conversely, psoriasis itself may affect pregnancy and fetal  outcomes.       Management  of psoriasis during pregnancy requires special consideration, as  several commonly used systemic therapies are contraindicated. This  review summarizes current evidence regarding the course of psoriasis  during pregnancy, associated maternal and fetal outcomes, and  therapeutic management. The aim is to support clinicians in  optimizing disease control while minimizing risks to both the mother  and the fetus and maintaining quality of life. ",
author="Ifamela, Novita
and Umborowati, Menul",
pages="34--40",
doi="10.5114/dr.2026.162056",
url="http://dx.doi.org/10.5114/dr.2026.162056"
}